Authors:
Ippolito, A
Veila, V
La Rosa, GL
Pellegriti, G
Vigneri, R
Belfiore, A
Citation: A. Ippolito et al., Immunostaining for Met/HGF receptor may be useful to identify malignanciesin thyroid lesions classified suspicious at fine-needle aspiration biopsy, THYROID, 11(8), 2001, pp. 783-787
Authors:
Pellegriti, G
Scollo, C
Giuffrida, D
Vigneri, R
Squatrito, S
Pezzino, V
Citation: G. Pellegriti et al., Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer, THYROID, 11(11), 2001, pp. 1025-1030
Authors:
Baudin, E
Pellegriti, G
Bonnay, M
Penfornis, A
Laplanche, A
Vassal, G
Schlumberger, M
Citation: E. Baudin et al., Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p ' DDD)levels on the treatment of patients with adrenocortical carcinoma, CANCER, 92(6), 2001, pp. 1385-1392
Authors:
Nocera, M
Baudin, E
Pellegriti, G
Cailleux, AF
Mechelany-Corone, C
Schlumberger, M
Citation: M. Nocera et al., Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine, BR J CANC, 83(6), 2000, pp. 715-718
Authors:
Leboulleux, S
Baudin, E
Young, J
Caillou, B
Lazar, V
Pellegriti, G
Ducreux, M
Schaison, G
Schlumberger, M
Citation: S. Leboulleux et al., Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma, EUR J ENDOC, 140(3), 1999, pp. 187-191